Smith+Nephew is a global medical technology company. We design and manufacture technology that takes the limits off living. We support healthcare professionals to return their patients to health and mobility, helping them to perform at their fullest potential.
From our first employee and founder, T.J. Smith, to our team today, it’s our people who make Smith+Nephew a unique place.
Yes, we love to innovate and develop exciting technologies, and we offer competitive salaries and progressive benefits. But it’s our culture - of Care, Collaboration and Courage - that really sets us apart.
Through a spirit of ownership and can-do attitude, we work together to win..
We’re a company of people who care about each other, about our customers and their patients, and about our communities.
Together, we fulfill our shared purpose of Life Unlimited.
Please note: not all products referred to may be approved for use or available in all markets.
Uses amniotic membrane preserved with patented cryopreservation method to create a new generation of ocular surface tissue therapies designed to accelerate the regeneration of damaged tissue while reducing recipient discomfort associated with ocular surface reconstruction.
Bio-Tissue offers the only commercially available amniotic membrane that preserves the native integrity, activity, and function exhibited by the tissue in utero for ocular surface wound repair and wound healing. Our proprietary processing and preservation method retains vital cytokines and growth factors which facilitate healing mechanisms such as:
• Anti-inflammatory
• Anti-scarring
• Anti-angiogenic
• Pain reduction
• Promotion of epithelial healing